(original) (raw)

TY - JOUR AU - Baxter, Nielson T. AU - Koumpouras, Charles C. AU - Rogers, Mary A. M. AU - Ruffin, Mack T. AU - Schloss, Patrick D. PY - 2016 DA - 2016/11/14 TI - DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model JO - Microbiome SP - 59 VL - 4 IS - 1 AB - There is a significant demand for colorectal cancer (CRC) screening methods that are noninvasive, inexpensive, and capable of accurately detecting early stage tumors. It has been shown that models based on the gut microbiota can complement the fecal occult blood test and fecal immunochemical test (FIT). However, a barrier to microbiota-based screening is the need to collect and store a patient’s stool sample. SN - 2049-2618 UR - https://doi.org/10.1186/s40168-016-0205-y DO - 10.1186/s40168-016-0205-y ID - Baxter2016 ER -